| Literature DB >> 28646553 |
Mohit Kumar Jolly1, Chris Ward2, Mathew Suji Eapen3,4, Stephen Myers3, Oskar Hallgren5, Herbert Levine1, Sukhwinder Singh Sohal3,4.
Abstract
Epithelial-mesenchymal transition (EMT) plays key roles during lung development and many lung diseases such as chronic obstructive pulmonary disease (COPD), lung cancer, and pulmonary fibrosis. Here, integrating morphological observations with underlying molecular mechanisms, we highlight the functional role of EMT in lung development and injury repair, and discuss how it can contribute to pathogenesis of chronic lung disease. We discuss the evidence of manifestation of EMT and its potential driving role in COPD, idiopathic pulmonary fibrosis (IPF), bronchiolitis obliterans syndrome (BOS), and lung cancer, while noting that all cells need not display a full EMT in any of these contexts, i.e., often cells co-express epithelial and mesenchymal markers but do not fully convert to extracellular matrix (ECM) -producing fibroblasts. Finally, we discuss recent therapeutic attempts to restrict EMT in chronic lung disease. Developmental Dynamics 247:346-358, 2018.Entities:
Keywords: chronic pulmonary obstructive disease (COPD); epithelial-mesenchymal transition (EMT); hybrid epithelial/mesenchymal; idiopathic pulmonary fibrosis (IPF); lung cancer
Mesh:
Year: 2017 PMID: 28646553 DOI: 10.1002/dvdy.24541
Source DB: PubMed Journal: Dev Dyn ISSN: 1058-8388 Impact factor: 3.780